Package 43817-906-01

{"route": ["SUBCUTANEOUS"], "spl_id": "dcfb97f4-4218-4d97-ba28-4f97dabe4ac0", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["9abb489d-ce54-4140-83f6-b756f00b0967"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Panacea Biotec Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (43817-906-01)  / 50 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "43817-906-01", "marketing_start_date": "20190506"}], "brand_name": "Azacitidine", "product_id": "43817-906_dcfb97f4-4218-4d97-ba28-4f97dabe4ac0", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "43817-906", "generic_name": "Azacitidine", "labeler_name": "Panacea Biotec Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/50mL"}], "application_number": "ANDA207234", "marketing_category": "ANDA", "marketing_start_date": "20190506", "listing_expiration_date": "20261231"}